HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development and prospects for bispecific antibody-based therapeutics in cancer and other applications.

AbstractBACKGROUND:
Progress in molecular biology for the production of bispecific antibodies (BiAbs) and the expanding knowledge on receptors on malignant and normal target cells provide the basis for developing new strategies using antibody- and/or receptor-based platform technology for the treatment of cancer and other diseases.
OBJECTIVE:
This review provides a preclinical and clinical perspective on application of bispecific antibodies for the treatment of solid tumors, hematologic malignancies and other diseases.
METHODS:
This review focuses on BiAb-based immunotherapy, clinical trials, alternative strategies, the challenges of technology and future applications.
RESULTS/CONCLUSION:
The successful application of a particular BiAb will depend on a thorough evaluation of the expected functional application and thoughtful engineering of structure, affinity and number of binding sites based on the desired function.
AuthorsLawrence G Lum, Zaid Al-Kadhimi
JournalExpert opinion on drug discovery (Expert Opin Drug Discov) Vol. 3 Issue 9 Pg. 1081-97 (Sep 2008) ISSN: 1746-0441 [Print] England
PMID23506181 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: